UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutic Strategy for Improving Motor Complications of Parkinson’s Disease: Short-Term Levodopa–Carbidopa Intestinal Gel Therapy Using a Nasogastric Tube

Journal Of Movement Disorders, 2024, 17(3), , pp.333-335

2024

Volltextzugriff (PDF)

Clinical manifestations of nonmotor symptoms in 1021 japanese Parkinson's disease patients from 35 medical centers

Parkinsonism & related disorders, 2017-05, Vol.38, p.54-60

2017

Volltextzugriff (PDF)

Prolonged Maturation Culture Favors a Reduction in the Tumorigenicity and the Dopaminergic Function of Human ESC-Derived Neural Cells in a Primate Model of Parkinson's Disease

Stem cells (Dayton, Ohio), 2012-05, Vol.30 (5), p.935-945

2012

Volltextzugriff (PDF)

Update on Deep Brain Stimulation for Dyskinesia and Dystonia: A Literature Review

Neurologia medico-chirurgica, 2016, Vol.56(5), pp.236-248

2016

Volltextzugriff (PDF)

Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model

The Journal of clinical investigation, 2005-01, Vol.115 (1), p.102-109

2005

Volltextzugriff (PDF)

Altered plasticity of the human motor cortex in Parkinson's disease

Annals of neurology, 2006-01, Vol.59 (1), p.60-71

2006

Volltextzugriff (PDF)

Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease

Journal of neuroscience methods, 2010-07, Vol.190 (2), p.198-204

2010

Volltextzugriff (PDF)

Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease

Journal of Parkinson's disease, 2011, Vol.1 (4), p.395-412

2011

Volltextzugriff (PDF)

Subthalamic nucleus deep brain stimulation restores normal rapid eye movement sleep in Parkinson's disease

Movement disorders, 2011-11, Vol.26 (13), p.2418-2422

2011

Volltextzugriff (PDF)

Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics

BMC neurology, 2017-02, Vol.17 (1), p.35-35, Article 35

2017

Volltextzugriff (PDF)

Prescription trends in Japanese advanced Parkinson's disease patients with non-motor symptoms: J-FIRST

PloS one, 2024-10, Vol.19 (10), p.e0309297

2024

Volltextzugriff (PDF)

A novel composite targeting method using high-field magnetic resonance imaging for subthalamic nucleus deep brain stimulation

Journal of neurosurgery, 2009-10, Vol.111 (4), p.737-745

2009

Volltextzugriff (PDF)

Mutations in CHCHD2 cause α-synuclein aggregation

Human molecular genetics, 2019-12, Vol.28 (23), p.3895-3911

2019

Volltextzugriff (PDF)

Risk factors for developing dyskinesia among Parkinson's disease patients with wearing-off: J-FIRST

Journal of the neurological sciences, 2023-05, Vol.448, p.120619-120619, Article 120619

2023

Volltextzugriff (PDF)

Non-motor symptoms depending on motor severity in Japanese patients with Parkinson's disease: A multicenter cross-sectional study

Journal of the neurological sciences, 2020-05, Vol.412, p.116641-116641, Article 116641

2020

Volltextzugriff (PDF)

Tongue tremor as a manifestation of atypical Parkinsonism treated with coaxial deep brain stimulation of thalamus and subthalamic area

Parkinsonism & related disorders, 2017-11, Vol.44, p.154-156

2017

Volltextzugriff (PDF)

Influence of istradefylline on non-motor symptoms of Parkinson's disease: A subanalysis of a 1-year observational study in Japan (J-FIRST)

Parkinsonism & related disorders, 2021-10, Vol.91, p.115-120

2021

Volltextzugriff (PDF)

STN-DBS affects the REM switch

Neuroscience research, 2009, Vol.65, p.S246-S246

2009

Volltextzugriff (PDF)

Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study

Movement disorders, 2015-09, Vol.30 (10), p.1343-1350

2015

Volltextzugriff (PDF)

Randomized, double‐blind, multicenter trial of hydrogen water for Parkinson's disease

Movement disorders, 2018-09, Vol.33 (9), p.1505-1507

2018

Volltextzugriff (PDF)

Factors associated with progression of non‐motor symptoms and deterioration in quality of life in Parkinson's disease: Results of J‐ FIRST , a 1‐year observational study

Neurology and clinical neuroscience, 2024-08

2024

Volltextzugriff (PDF)

Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model

The Journal of clinical investigation, 2005-01, Vol.115 (1), p.102-109

2005

Volltextzugriff (PDF)

Oral venglustat in Parkinson disease patients with a mutation: Study design of part 2 of the MOVES-PD trial and patient characteristics

Molecular genetics and metabolism, 2021-02, Vol.132 (2), p.S85

2021

Volltextzugriff (PDF)

Oral venglustat in Parkinson disease patients with a GBA mutation: Study design of part 2 of the MOVES-PD trial and patient characteristics

Molecular genetics and metabolism, 2021-02, Vol.132 (2), p.S85-S85

2021

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(41)

Publikationsform

Sprache

Englisch
(43)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study

Therapeutic Strategy for Improving Motor Complications of Parkinson’s Disease: Short-Term Levodopa–Carbidopa Intestinal Gel Therapy Using a Nasogastric Tube

Clinical manifestations of nonmotor symptoms in 1021 japanese Parkinson's disease patients from 35 medical centers

Prolonged Maturation Culture Favors a Reduction in the Tumorigenicity and the Dopaminergic Function of Human ESC-Derived Neural Cells in a Primate Model of Parkinson's Disease

Update on Deep Brain Stimulation for Dyskinesia and Dystonia: A Literature Review

Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model

Altered plasticity of the human motor cortex in Parkinson's disease

Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease

Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease

Subthalamic nucleus deep brain stimulation restores normal rapid eye movement sleep in Parkinson's disease

Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics

Prescription trends in Japanese advanced Parkinson's disease patients with non-motor symptoms: J-FIRST

A novel composite targeting method using high-field magnetic resonance imaging for subthalamic nucleus deep brain stimulation

Mutations in CHCHD2 cause α-synuclein aggregation

Risk factors for developing dyskinesia among Parkinson's disease patients with wearing-off: J-FIRST

Non-motor symptoms depending on motor severity in Japanese patients with Parkinson's disease: A multicenter cross-sectional study

Tongue tremor as a manifestation of atypical Parkinsonism treated with coaxial deep brain stimulation of thalamus and subthalamic area

Influence of istradefylline on non-motor symptoms of Parkinson's disease: A subanalysis of a 1-year observational study in Japan (J-FIRST)

STN-DBS affects the REM switch

Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study

Randomized, double‐blind, multicenter trial of hydrogen water for Parkinson's disease

Factors associated with progression of non‐motor symptoms and deterioration in quality of life in Parkinson's disease: Results of J‐ FIRST , a 1‐year observational study

Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model

Oral venglustat in Parkinson disease patients with a mutation: Study design of part 2 of the MOVES-PD trial and patient characteristics

Oral venglustat in Parkinson disease patients with a GBA mutation: Study design of part 2 of the MOVES-PD trial and patient characteristics

Suchergebnisse filtern